News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Foresite Capital Management V, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/19/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 523,450 shares
@ $2.97, valued at
$1.6M
Bought 176,550 shares
@ $2.97, valued at
$524.4k
|
|
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2023 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 1,550,956 shares
@ $2.8, valued at
$4.3M
Bought 229,044 shares
@ $2.8, valued at
$641.3k
|
|
| 02/22/2023 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Acquired 1,100,000 shares
@ $0 |
|
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/03/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 250,000 shares
@ $5, valued at
$1.3M
Bought 250,000 shares
@ $5, valued at
$1.3M
|
|
| 12/05/2022 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Bought 637,420 shares
@ $0.85, valued at
$541.8k
|
|
| 06/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/30/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/03/2021 |
4
| Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Disposed of 1,954,904 shares
@ $0
Acquired 8,276 shares
@ $0 |
|
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/23/2021 |
4
| FS Development Holdings II, LLC (10% Owner) has filed a Form 4 on FS Development Corp. II|
Txns:
| Bought 602,500 shares
@ $10, valued at
$6M
|
|
| 02/16/2021 |
3
| FS Development Holdings II, LLC (10% Owner) has filed a Form 3 on FS Development Corp. II |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2021 |
4
| FS Development Holdings, LLC (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 1,500,000 shares
@ $10, valued at
$15M
Converted 2,928,750 shares
@ $0
Converted 2,928,750 options to buy
@ $0 |
|
| 12/09/2020 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Converted 9,171,643 shares
@ $0
Converted 500,001 shares
@ $0
Converted 166,667 shares
@ $0
Converted 6,347,893 preferred shares
@ $0
Converted 298,465 preferred shares
@ $0
Converted 99,488 preferred shares
@ $0
Converted 2,666,002 preferred shares
@ $0
Converted 55,922 preferred shares
@ $0
Converted 18,641 preferred shares
@ $0
Converted 157,222 preferred shares
@ $0
Converted 145,128 preferred shares
@ $0 |
|
| 12/04/2020 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 500,000 shares
@ $20, valued at
$10M
Granted 375,000 shares
@ $20, valued at
$7.5M
Granted 125,000 shares
@ $20, valued at
$2.5M
|
|
| 12/03/2020 |
3
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 3 on Kinnate Biopharma Inc. |
| 10/19/2020 |
4
| FS Development Holdings, LLC (10% Owner) has filed a Form 4 on FS Development Corp.|
Txns:
| Bought 441,500 shares
@ $10, valued at
$4.4M
|
|
| 08/19/2020 |
3/A
| FS Development Holdings, LLC (10% Owner) has filed a Form 3/A on FS Development Corp. |
|
|